News about Global Pharma

Zydus Announces USFDA Orphan Drug Designation to Usnoflast for Treatment of ALS

Zydus has received USFDA Orphan Drug Designation for Usnoflast, a novel oral NLRP3 inhibitor, for the treatment of amyotrophic lateral sclerosis (ALS).

Global Pharma | 23/01/2025 | By Manvi |  324

Conduit and Agility to Develop Enhanced Formulations for its Autoimmune Pipeline

Conduit has developed a series of novel, advantageous solid forms of all its autoimmune pipeline assets, each protected by newly established composition-of-matter intellectual property (IP).

Global Pharma | 23/01/2025 | By Aishwarya |  565

Emcure Pharmaceuticals Launches its R&D Centre in Ahmedabad

The Emcure Research Centre (ERC) is strategically designed to enable breakthroughs in complex drug delivery systems, such as sustained-release formulations, liposomal injections and advanced dermal therapies.

Global Pharma | 23/01/2025 | By Aishwarya |  1052

Syntegon Welcomes Eros Carletti as New Chief Financial Officer

Eros Carletti succeeds Dr. Peter Hackel, who left Syntegon on December 31, 2024, following two successful years as CFO.

Global Pharma | 23/01/2025 | By Aishwarya |  454

Strides Pharma Receives ESG Rating of 76/100 in S&P Global's Corporate Sustainability Assessment 2024

Strides Pharma Science Ltd. achieved a debut ESG score of 76/100 and a CSA score of 75/100 in S&P Global’s Corporate Sustainability Assessment. Strides has secured a position in the 94th percentile among its peers in the DRG Global Pharmaceuticals industry.

Global Pharma | 22/01/2025 | By Manvi |  240

Pharma Industry's Wishlist for Budget 2025: Key Expectations

The forthcoming Union Budget 2025 presents a pivotal opportunity for the Indian pharmaceutical sector to address existing challenges and pave the way for sustainable growth.

Global Pharma | 22/01/2025 | By Aishwarya |  1111

Hoth Therapeutics Announces Acquisition of New Patent Applications

Hoth Therapeutics continues to invest in robust research and development strategies, ensuring the protection and growth of its proprietary technologies.

Global Pharma | 22/01/2025 | By Aishwarya |  390

Strides Secures USFDA Approval for Acetaminophen and Ibuprofen Tablets, 125 mg/250 mg

Strides Pharma Science Ltd.'s subsidiary, Strides Pharma Global Pte. Ltd., has received USFDA approval for Acetaminophen and Ibuprofen Tablets (OTC), a dual-action pain relief product bioequivalent to Advil Dual Action.

Global Pharma | 21/01/2025 | By Manvi |  351

Cormica Acquires Zwisler Laboratorium to Expand European Business

This landmark acquisition marks Cormica’s first entry into the German market, a key milestone in its strategy to expand its European footprint.

Global Pharma | 21/01/2025 | By Aishwarya |  268

ReciBioPharm Bags Three Year Grant to Advance RNA Manufacturing

The funding will support the global deployment of xRNA Continuous Manufacturing technologies to LMICs with a strong focus on the development of state-of-the-art inline PAT capabilities and predictive analytics software.

Global Pharma | 21/01/2025 | By Aishwarya |  322